CUMBERLAND PHARMACEUTICALS (CPIX) Top Institutional Shareholders
CUMBERLAND PHARMACEUTICALS (CPIX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $8.83M in CPIX holdings during the latest filing period.
Ikarian Capital, Llc is currently the largest disclosed institutional shareholder of CPIX tracked by InsiderSet, reporting ownership valued at approximately $1.80M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $3.10M, representing an estimated gain of +72.62% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 88% of the total disclosed CPIX value among the investors covered in this analysis. Major shareholders include Ikarian Capital, Llc, Renaissance Technologies LLC, Vanguard Capital Management Llc, and several other long-term asset managers with concentrated positions in CUMBERLAND PHARMACEUTICALS (CPIX).
This page ranks the largest institutional CPIX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
28
Total Reported Value
$8.83M
Largest Holder
Ikarian Capital, Llc
Largest Position
$1.80M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
36
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Ikarian Capital, Llc | 0.26% | 553,153 | $1,797,748 | $3,103,188 | +$1,305,440 | +72.62% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 470,696 | $1,529,762 | $2,640,605 | +$1,110,843 | +72.62% |
| Vanguard Capital Management Llc | 0.00% | 361,759 | $1,175,717 | $2,029,468 | +$853,751 | +72.62% | |
| Dimensional Fund Advisors Lp | 0.00% | 276,359 | $898,167 | $1,550,374 | +$652,207 | +72.62% | |
| Perceptive Advisors Llc | 0.01% | 196,978 | $640,179 | $1,105,047 | +$464,868 | +72.62% | |
| Bridgeway Capital Management, Llc | 0.01% | 163,468 | $531,271 | $917,055 | +$385,784 | +72.62% | |
| Boothbay Fund Management, Llc | 0.01% | 127,694 | $415,006 | $716,363 | +$301,357 | +72.62% | |
| Geode Capital Management, Llc | 0.00% | 114,293 | $371,499 | $641,184 | +$269,685 | +72.59% | |
| J. Goldman & Co Lp | 0.01% | 81,040 | $263,380 | $454,634 | +$191,254 | +72.62% | |
| Bank Of New York Mellon Corp | 0.00% | 58,458 | $189,988 | $327,949 | +$137,961 | +72.62% | |
| Blackrock, Inc. | 0.00% | 56,891 | $184,896 | $319,159 | +$134,263 | +72.62% | |
| Vanguard Fiduciary Trust Co | 0.00% | 45,623 | $148,275 | $255,945 | +$107,670 | +72.62% | |
| State Street Corp | 0.00% | 39,510 | $128,408 | $221,651 | +$93,243 | +72.61% | |
| Marex Group Plc | 0.00% | 36,423 | $118,375 | $204,333 | +$85,958 | +72.62% | |
| Xtx Topco Ltd | 0.00% | 24,006 | $78,020 | $134,674 | +$56,654 | +72.61% | |
| Arrowstreet Capital, Limited Partnership | 0.00% | 20,252 | $65,819 | $113,614 | +$47,795 | +72.62% | |
| Northern Trust Corp | 0.00% | 19,603 | $63,710 | $109,973 | +$46,263 | +72.61% | |
| Cresset Asset Management, Llc | 0.00% | 19,475 | $63,294 | $109,255 | +$45,961 | +72.61% | |
| Citadel Advisors Llc | 0.00% | 16,643 | $54,090 | $93,367 | +$39,277 | +72.61% | |
| Jane Street Group, Llc | 0.00% | 14,607 | $47,473 | $81,945 | +$34,472 | +72.61% | |
| Two Sigma Investments, Lp | 0.00% | 11,085 | $36,026 | $62,187 | +$26,161 | +72.62% | |
| Ubs Group Ag | 0.00% | 5,189 | $16,864 | $29,110 | +$12,246 | +72.62% | |
| Morgan Stanley | 0.00% | 3,260 | $10,595 | $18,289 | +$7,694 | +72.62% | |
| Wells Fargo & Company/Mn | 0.00% | 100 | $325 | $561 | +$236 | +72.62% | |
| Acadian Asset Management Llc | 0.00% | 44,288 | $143 | $248,456 | +$248,313 | +173645.23% | |
| Caitong International Asset Management Co., Ltd | 0.00% | 2 | $6 | $11 | +$5 | +87.00% | |
| Huntington National Bank | 0.00% | 1 | $3 | $6 | +$3 | +87.00% | |
| Capital Advisors, Ltd. Llc | 0.00% | 437 | $1 | $2,452 | +$2,451 | +245057.00% |
Frequently asked questions about CPIX
Who owns the most CPIX stock?
The largest holders of CPIX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for CUMBERLAND PHARMACEUTICALS (CPIX).
Is CPIX widely held by superinvestors?
Many widely followed stocks like CPIX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly CPIX is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.